These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37900306)

  • 1. Screening of the novel antimicrobial drug, XF-73, against 2,527
    Rhys-Williams W; Galvin HM; Love WG
    Front Cell Infect Microbiol; 2023; 13():1264456. PubMed ID: 37900306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the potential for mutational resistance to XF-73, retapamulin, mupirocin, fusidic acid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus isolates during a 55-passage study.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1177-81. PubMed ID: 21149626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    Yoneda A; Thänert R; Burnham CD; Dantas G
    Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant
    Wu X; Yu H; He LY; Wang CQ; Xu HM; Zhao RQ; Jing CM; Chen YH; Chen J; Deng JK; Shi J; Lin AW; Li L; Deng HL; Cai HJ; Chen YP; Wen ZW; Yang JH; Zhang T; Xiao FF; Cao Q; Huang WC; Hao JH; Zhang CH; Huang YY; Ji XF
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):628-634. PubMed ID: 32842382
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
    Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
    J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus.
    Vaudaux P; Huggler E; Rhys-Williams W; Love WG; Lew DP
    Int J Antimicrob Agents; 2011 Jun; 37(6):576-9. PubMed ID: 21414759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a Novel Antibacterial Agent Exeporfinium Chloride, (XF-73), Against Antibiotic-Resistant Bacteria in Mouse Superficial Skin Infection Models.
    Zhang C; Li J; Lu R; Wang S; Fu Z; Yao Z
    Infect Drug Resist; 2023; 16():4867-4879. PubMed ID: 37520450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.
    Sader HS; Flamm RK; Jones RN
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3178-81. PubMed ID: 23629712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-staphylococcal lysin, LSVT-1701, activity: In vitro susceptibility of Staphylococcus aureus and coagulase-negative staphylococci (CoNS) clinical isolates from around the world collected from 2002 to 2019.
    Huang DB; Sader HS; Rhomberg PR; Gaukel E; Borroto-Esoda K
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115471. PubMed ID: 34280671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
    Crandon JL; Banevicius MA; Nicolau DP
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial and Antibiofilm Potency of XF Drugs, Impact of Photodynamic Activation and Synergy With Antibiotics.
    Board-Davies EL; Rhys-Williams W; Hynes D; Williams D; Farnell DJJ; Love W
    Front Cell Infect Microbiol; 2022; 12():904465. PubMed ID: 35846763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and characteristics of methicillin-resistant and -susceptible Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from Japanese retail ready-to-eat raw fish.
    Hammad AM; Watanabe W; Fujii T; Shimamoto T
    Int J Food Microbiol; 2012 Jun; 156(3):286-9. PubMed ID: 22541390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types.
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Int J Antimicrob Agents; 2014 Apr; 43(4):323-7. PubMed ID: 24411474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of tigecycline against methicillin-resistant staphylococci].
    Tunçkanat F; Saribaş Z; Ercis S
    Mikrobiyol Bul; 2009 Apr; 43(2):211-5. PubMed ID: 19621605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid minimum inhibitory concentration (MIC) creep in methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates at a single Japanese center.
    Miyazaki M; Nagata N; Miyazaki H; Matsuo K; Takata T; Tanihara S; Kamimura H
    Biol Pharm Bull; 2014; 37(4):679-82. PubMed ID: 24694615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, multiple antibiotic resistance and virulence profile of methicillin-resistant
    Igbinosa EO; Beshiru A; Igbinosa IH; Ogofure AG; Ekundayo TC; Okoh AI
    Front Cell Infect Microbiol; 2023; 13():1122059. PubMed ID: 36936767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
    Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
    BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.